Contact Us: 01282 426380
KM Financial Solutions | China’s Hua Medicine plans $400m Hong Kong IPO, led by Goldman – sources
11768
post-template-default,single,single-post,postid-11768,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

China’s Hua Medicine plans $400m Hong Kong IPO, led by Goldman – sources

08 Mar China’s Hua Medicine plans $400m Hong Kong IPO, led by Goldman – sources

Posted at 08:29h in News by
0 Likes
HONG KONG, March 9 (Reuters) – Chinese drug developer Hua
Medicine is planning to raise at least $400 million in an
initial public offer in Hong Kong in the latest in a series of
biotech floats in the city, said people with knowledge of the
matter.

No Comments

Sorry, the comment form is closed at this time.